Simplex Trading
NGNE icon

Simplex Trading’s Neurogene NGNE Stock Holding History

Simplex Trading’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$64.5K Buy
+3,200
New +$62K ﹤0.01% 5582
2025
Q3 		– Sell
-500
Closed -$7K – 9713
2025
Q2 		$7K Sell
500
-15,400
-97% -$242K ﹤0.01% 7564
2025
Q1 		$186K Sell
15,900
-4,300
-21% -$74.7K ﹤0.01% 4421
2024
Q4 		$461K Buy
+20,200
New +$752K ﹤0.01% 3629
2022
Q3 		– Sell
-570
Closed -$11K – 10555
2022
Q2 		$11K Sell
570
-200
-26% -$4.88K ﹤0.01% 8209
2022
Q1 		$28K Buy
770
+265
+52% +$15.5K ﹤0.01% 7851
2021
Q4 		$48K Buy
505
+365
+261% +$44.5K ﹤0.01% 7317
2021
Q3 		$27K Hold
140
– – ﹤0.01% 8165
2021
Q2 		$25K Buy
+140
New +$31K ﹤0.01% 8390
2021
Q1 		– Sell
-1
Closed -$256 – 8377
2020
Q4 		$21K Buy
+1
New +$244 ﹤0.01% 6944
2020
Q3 		– Sell
-2
Closed -$78K – 8240
2020
Q2 		$78K Sell
2
-2
-50% -$521 ﹤0.01% 5063
2020
Q1 		$89K Sell
4
-6
-60% -$1.24K ﹤0.01% 4494
2019
Q4 		$256K Buy
+10
New +$996 ﹤0.01% 3493
2019
Q1 		– Sell
-28
Closed -$120K – 7606
2018
Q4 		$120K Buy
28
+12
+75% +$585 ﹤0.01% 3667
2018
Q3 		$90K Sell
16
-11
-41% -$649 ﹤0.01% 4541
2018
Q2 		$142K Buy
27
+26
+2,600% +$6.78K ﹤0.01% 3881
2018
Q1 		$10K Buy
+1
New +$276 ﹤0.01% 4035
2017
Q3 		– Sell
-4
Closed -$8K – 6376
2017
Q2 		$8K Buy
+4
New +$1.15K ﹤0.01% 4180
2017
Q1 		– Hold
0
– -$2K – 6570
2016
Q4 		– Sell
-5
Closed -$1.34K – 5088
2016
Q3 		$17K Buy
+5
New +$1.01K ﹤0.01% 3132

Other funds holding NGNE

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Simplex Trading's NGNE Position: Q1 2026 in Review

Simplex Trading increased its Neurogene (NGNE) stake by 44% in Q1 2026, buying an estimated $523 and bringing the position to 89 shares worth $1.79K. The position accounts for ﹤0.01% of the portfolio, ranked #8410.

Simplex Trading first reported a position in NGNE in Q4 2016 and has held it in 19 quarters since. The position peaked at $96K in Q1 2018. 96 funds tracked by Wall St. Rank hold NGNE as of Q1 2026.

  • Simplex Trading held 89 shares of Neurogene worth $1.79K as of Q1 2026.
  • Simplex Trading bought 27 Neurogene shares in Q1 2026, an estimated $523.
  • Neurogene made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8410 holding.
  • Simplex Trading first reported a position in Neurogene in Q4 2016 and has held it in 19 quarters since.
  • Simplex Trading's Neurogene position peaked at $96K in Q1 2018.
  • 96 funds tracked by Wall St. Rank held Neurogene as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.